glp 1 and weed GLP-1 medications get at the heart of addiction: study – WashU Medicine Ozempic and Cannabis: Risks, Benefits,

Atarashi, K

Ipamorelin is a growth hormonereleasing peptide that is sometimes used in clinical wellness settings under medical supervision

Landmark trials (SUSTAIN and SELECT series) demonstrate that GLP-1 receptor agonists like semaglutide reduce body weight by 1022% over 68 weeks and lower cardiovascular events by 20% in patients with obesity and heart disease

Alopecia Although some studies have reported increased rates of alopecia following GLP-1 agonist treatment, others have speculated about the potential role of these medications in treating hair loss through improved insulin sensitivity and scalp blood flow